Early Detection Research Network

SELL

Aliases:
This biomarker is also known as:
  • CD62L,
  • PLNHR,
  • Lymph node homing receptor,
  • hLHRc,
  • pln homing receptor,
  • Leukocyte adhesion molecule 1,
  • LAM-1,
  • LEU8,
  • lymph node homing receptor,
  • TQ1,
  • Lyam-1,
  • L-selectin,
  • lymphocyte adhesion molecule 1,
  • LNHR,
  • LECAM1,
  • Leukocyte-endothelial cell adhesion molecule 1,
  • gp90-MEL,
  • selectin L,
  • LAM1,
  • LSEL,
  • leukocyte surface antigen Leu-8,
  • SELL,
  • LYAM1,
  • sL-selectin,
  • Leukocyte surface antigen Leu-8,
  • CD62L antigen,
  • Leu-8,
  • CD62 antigen-like family member L,
  • leukocyte-endothelial cell adhesion molecule 1,

Description…

From NCBI Gene and UniProtKB/Swiss-Prot: sL-selectin, also known as SELL, is a cell surface adhesion molecule that belongs to a family of adhesion/homing receptors. SELL mediates the adherence of lymphocytes to endothelial cells of high endothelial venules in peripheral lymph nodes and promotes initial tethering and rolling of leukocytes in endothelia, facilitating their migration into secondary lymphoid organs and inflammation sites. SELL contains a C-type lectin-like domain, a calcium-binding epidermal growth factor-like domain, and two short complement-like repeats. Alternatively spliced transcript variants have been found for this gene.

Datasets

There are no datasets associated with this biomarker.

Attributes
QA State: Curated
Type: Protein
HGNC Name: SELL

The following organs have data associated with this biomarker…

Attributes

Phase: One
QA State: Under Review
Organ-specific information for this biomarker is currently being annotated or is under review. You must be logged in or do not have permission to view any additional information. Contact the Informatics Center if you should have access to this biomarker.

Attributes

Phase: Two
QA State: Curated
Organ-specific information for this biomarker is currently being annotated or is under review. You must be logged in or do not have permission to view any additional information. Contact the Informatics Center if you should have access to this biomarker.

This biomarker is currently being annotated or is under review. You must be logged in or do not have permission to view any additional information. Contact the Informatics Center if you should have access to this biomarker.